The Business Times
business-time-50

Moderna

Companies & Markets

Moderna’s 177% surge burns shorts in ‘painful’ US$5.5 billion loss

2026-08-20T09:58:23.000Z
Moderna is cutting costs as revenue from its Covid vaccine shrinks and the company faces new challenges from the leadership of Health and Human Services Secretary Robert F Kennedy Jr, a vaccine critic.
Consumer & Healthcare

Moderna to cut 10% of staff to offset slowing Covid business

2025-07-31T11:53:14.000Z
Moderna has been under pressure to find new sources of revenue as its Covid vaccine sales fall sharply and it spends heavily on its pipeline.
Consumer & Healthcare

Trump team weighs pulling funds for Moderna bird flu vaccine

2025-02-27T04:12:07.000Z
Moderna posted a profit of US$13 million, or three cents a share, for the quarter, compared to a loss of US$3.6 billion a year ago.
Consumer & Healthcare

Moderna reports surprise profit on higher-than-expected Covid vaccine sales

2024-11-07T15:40:00.000Z
Moderna reported a net loss of US$1.3 billion, or US$3.33 per share, for the second quarter.
Consumer & Healthcare

Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026

2024-08-01T10:51:33.000Z
Moderna says the funds will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.
Consumer & Healthcare

US awards Moderna US$176 million to produce bird flu vaccine

2024-07-02T13:33:54.000Z
Moderna’s shot, called mRESVIA, will compete with products that arrived last year from GSK and Pfizer. 
Companies & Markets

Moderna’s RSV shot wins FDA approval for use in older adults

2024-06-01T04:10:47.000Z
Quarterly revenues of US$167 million topped analysts’ expectations of about US$100 million – but dropped sharply from the US$1.9 billion in sales posted during the same period a year ago.
Companies & Markets

Moderna beats quarterly estimates as cost-cutting pares losses

2024-05-02T11:30:40.000Z
Moderna posted quarterly revenue of US$2.8 billion for its Covid-19 vaccine, including US$800 million in US sales and US$2 billion of international sales.
Companies & Markets

Moderna beats sales estimates as Covid shot gains market share

2024-02-22T12:25:33.000Z
Metagenomi will aim to list on the Nasdaq under the symbol “MGX”.
Companies & Markets

Moderna, Bayer-backed startup Metagenomi files for US IPO

2024-01-06T00:36:13.000Z
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More